Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell and gene therapies and help ensure consistent safety and efficacy ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

The hammer came down on an unspecified number of FDA employees this weekend, days after Robert F. Kennedy Jr. was confirmed ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

Every day, hospitals throughout the U.S. transfuse blood or blood components, such as platelets, to save the lives of people ...

announced today the opening of its cutting-edge Center of Excellence for Biologics and Cell and Gene Therapy in the heart of Research Triangle Park (RTP), North Carolina. The new facility expands ...

NVIDIA (NASDAQ: NVDA) has introduced Evo 2, an advanced artificial intelligence (AI) system aimed at transforming the field ...

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

Spanning 50,000 square feet, the new center is ... small molecules, biologics, and cell and gene therapies. Solvias offers end-to-end solutions from raw material testing to drug product release ...

The biologics drug substance manufacturing market ... of-the-art biologics manufacturing with a clinical research and development center, reinforcing BeiGene's position as a leader in oncology ...